JDRF

Diabetes Advocacy Orgs: 2011 Milestones and What to Expect in 2012

By AmyT on December 29, 2011

We wrapped up the year here at DiabetesMine with our traditional year in review post — outlining everything we thought was BIG for our year in diabetes. That got us thinking:
What did the major diabetes advocacy organizations and patient communities in this country believe were their biggest accomplishments in 2011? How would they describe the year? And what are their flagship plans / goals / strategies for continuing to help the diabetes community in…

Read more »

NewsFlash: FDA Releases Guidance on Artificial Pancreas Development

By AmyT on December 2, 2011

Yesterday marks “a milestone” in the development of new technology to help automate the care and treatment of type 1 diabetes, according to JDRF!
The U.S. Food and Drug Administration unveiled its eagerly awaited Draft Guidance document for research and development of the Artificial Pancreas system, and initial reaction from JDRF — in a press conference held yesterday afternoon — was a mix of jubilation and a more measured response that they remain “guardedly optimistic” about the details…

Read more »

JDRF’s Silicon Valley FDA Breakfast

By AmyT on November 29, 2011

Ten days ago, I got a last-minute invitation to attend a small Bay Area JDRF event at the Four Seasons Hotel in Palo Alto, in the heart of Silicon Valley. This is where technology happens. It turns out, this diabetes-tech-update event has been going on for a few years. I was especially excited, because the theme of this year’s program was FDA Reform: How Can We Remain Competitive While Protecting Public Safety? Now that sounded…

Read more »

On JDRF’s Gonzo NY Times Ad

By AmyT on November 7, 2011

We probably don’t need to tell you that the Diabetes Online Community is all abuzz over the full-page ad that JDRF ran in The New York Times and in The Washington Post last week. It’s quite the shock campaign… and most of the buzz has been about that 1 in 20 statistic. Can it possibly be accurate that so many people with diabetes die of low blood sugar?!

 
JDRF stands behind the statistic, citing…

Read more »

Grappling with FDA Over Low-Glucose Suspend

By AmyT on September 27, 2011

Wondering why all the latest and greatest diabetes technology seems to get launched only in Europe these days? Wait, it gets worse…
Did you know that 40 different countries around the world have approved new Low-Glucose Suspend (LGS) technology — which allows a CGMS-augmented insulin pump to automatically shut off basal insulin when it detects a BG reading below the target range, an amazing safety feature! — yet FDA is still not anywhere close to being…

Read more »